Risankizumab

ATC L04AC18 · 10 markets · 47 records

Risankizumab 10 markets · 47 records Forms

GB 7 records · 6 strengths

600 mg/10 mLinjectionSkyrizi 600mg/10ml concentrate for solution for infusion vials also in US·SG·TW
180 mg/1.2 mLinjectionSkyrizi 360mg/2.4ml solution for injection cartridges also in US·SG
150 mg/1 mLinjectionSkyrizi 150mg/1ml solution for injection pre-filled pens+1Skyrizi 75mg/0.83ml solution for injection pre-filled syringes also in AU
360 mg/2.4 mLinjectionSkyrizi 360mg/2.4ml solution for injection cartridges also in SG
55 mg/0.37 mLinjectionSkyrizi 75mg/0.83ml solution for injection pre-filled syringes also in US
75 mg/0.83 mLinjectionSkyrizi 75mg/0.83ml solution for injection pre-filled syringes

CA 7 records · 5 strengths

150 mgliquidSkyrizi
150 mg/1 mLliquidSkyrizi
90 mgliquidSkyrizi
60 mgliquidSkyrizi
55 mgliquidSkyrizi

AU 7 records · 6 strengths

150 mginjectionSKYRIZI risankizumab 150 mg/mL solution for injection pre-filled pen+1SKYRIZI risankizumab 150 mg/mL solution for injection pre-filled syringe also in US·SG·ES +1 unknown
150 mg/1 mLinjectionSkyrizi also in GB
600 mginjectionSKYRIZI risankizumab 600 mg/10 mL concentrate solution for intravenous infusion vial also in ES unknown
360 mginjectionSKYRIZI risankizumab 360 mg/2.4 mL solution for injection pre-filled cartridge with on-body delivery system also in ES unknown
180 mginjectionSKYRIZI risankizumab 360 mg/2.4 mL solution for injection pre-filled cartridge with on-body delivery system also in ES unknown

Records without a stated strength · 1 Skyrizi

US 6 records · 4 strengths

150 mginjectionSkyrizi also in AU·SG·ES +1
600 mg/10 mLinjectionSkyrizi also in GB·SG·TW
180 mg/1.2 mLinjectionSkyrizi also in GB·SG
55 mg/0.37 mLinjectionSkyrizi also in GB

SG 5 records · 5 strengths

150 mginjectionSKYRIZI SOLUTION FOR INJECTION IN PRE-FILLED PEN 150MG/ML also in AU·US·ES +1
600 mg/10 mLinjectionSKYRIZI CONCENTRATE FOR SOLUTION FOR INFUSION 600MG/10ML also in GB·US·TW
180 mg/1.2 mLinjectionSKYRIZI SOLUTION FOR INJECTION IN PRE-FILLED CARTRIDGE WITH ON-BODY INJECTOR 360MG/2.4ML also in GB·US
360 mg/2.4 mLinjectionSKYRIZI SOLUTION FOR INJECTION IN PRE-FILLED CARTRIDGE WITH ON-BODY INJECTOR 360MG/2.4ML also in GB
150 mg/mLinjectionSKYRIZI SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 150MG/ML

ES 5 records · 4 strengths

150 mginjectionSKYRIZI PRECARGADA also in AU·US·SG +1
600 mginjectionSkyrizi also in AU
360 mginjectionSkyrizi also in AU
180 mginjectionSkyrizi also in AU

HK 4 records · 1 strengths

Records without a stated strength · 1 SKYRIZI CONCENTRATE FOR SOLUTION FOR INFUSION 600MG/10ML、SKYRIZI SOLUTION FOR INJECTION IN CARTRIDGE 360MG/2.4ML、SKYRIZI SOLUTION FOR INJECTION IN PRE-FILLED PEN 150MG/1ML、SKYRIZI SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 150MG/1ML +1

TW 2 records · 2 strengths

150 mginjectionSKYRIZI 150 mg/ml solution for+1喜開悅150 mg/ml注射劑 also in AU·US·SG +1
600 mg/10 mLinjectionSKYRIZI Concentrate for Solution for infusion 600mg/10ml Vial+1喜開悅靜脈注射劑600毫克/10毫升 also in GB·US·SG

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 Skyrizi

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	ES	TW	HK	EU
150 mg injection	Skyrizi	not recorded	not recorded	SKYRIZI risankizumab 150 mg/mL solution for injection pre-filled pen SKYRIZI risankizumab 150 mg/mL solution for injection pre-filled syringe	SKYRIZI SOLUTION FOR INJECTION IN PRE-FILLED PEN 150MG/ML	SKYRIZI PRECARGADA	SKYRIZI 150 mg/ml solution for 喜開悅150 mg/ml注射劑	not recorded	not recorded
600 mg/10 mL injection	Skyrizi	Skyrizi 600mg/10ml concentrate for solution for infusion vials	not recorded	not recorded	SKYRIZI CONCENTRATE FOR SOLUTION FOR INFUSION 600MG/10ML	not recorded	SKYRIZI Concentrate for Solution for infusion 600mg/10ml Vial 喜開悅靜脈注射劑600毫克/10毫升	not recorded	not recorded
180 mg/1.2 mL injection	Skyrizi	Skyrizi 360mg/2.4ml solution for injection cartridges	not recorded	not recorded	SKYRIZI SOLUTION FOR INJECTION IN PRE-FILLED CARTRIDGE WITH ON-BODY INJECTOR 360MG/2.4ML	not recorded	not recorded	not recorded	not recorded
150 mg/1 mL injection	not recorded	Skyrizi 150mg/1ml solution for injection pre-filled pens Skyrizi 75mg/0.83ml solution for injection pre-filled syringes	not recorded	Skyrizi	not recorded	not recorded	not recorded	not recorded	not recorded
600 mg injection	not recorded	not recorded	not recorded	SKYRIZI risankizumab 600 mg/10 mL concentrate solution for intravenous infusion vial	not recorded	Skyrizi	not recorded	not recorded	not recorded
360 mg/2.4 mL injection	not recorded	Skyrizi 360mg/2.4ml solution for injection cartridges	not recorded	not recorded	SKYRIZI SOLUTION FOR INJECTION IN PRE-FILLED CARTRIDGE WITH ON-BODY INJECTOR 360MG/2.4ML	not recorded	not recorded	not recorded	not recorded
360 mg injection	not recorded	not recorded	not recorded	SKYRIZI risankizumab 360 mg/2.4 mL solution for injection pre-filled cartridge with on-body delivery system	not recorded	Skyrizi	not recorded	not recorded	not recorded
180 mg injection	not recorded	not recorded	not recorded	SKYRIZI risankizumab 360 mg/2.4 mL solution for injection pre-filled cartridge with on-body delivery system	not recorded	Skyrizi	not recorded	not recorded	not recorded
55 mg/0.37 mL injection	Skyrizi	Skyrizi 75mg/0.83ml solution for injection pre-filled syringes	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
150 mg liquid	not recorded	not recorded	Skyrizi	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
150 mg/1 mL liquid	not recorded	not recorded	Skyrizi	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
90 mg liquid	not recorded	not recorded	Skyrizi	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
60 mg liquid	not recorded	not recorded	Skyrizi	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
55 mg liquid	not recorded	not recorded	Skyrizi	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
150 mg/mL injection	not recorded	not recorded	not recorded	not recorded	SKYRIZI SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 150MG/ML	not recorded	not recorded	not recorded	not recorded
75 mg/0.83 mL injection	not recorded	Skyrizi 75mg/0.83ml solution for injection pre-filled syringes	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	Skyrizi	not recorded	not recorded	not recorded	SKYRIZI CONCENTRATE FOR SOLUTION FOR INFUSION 600MG/10ML SKYRIZI SOLUTION FOR INJECTION IN CARTRIDGE 360MG/2.4ML SKYRIZI SOLUTION FOR INJECTION IN PRE-FILLED PEN 150MG/1ML +1 SKYRIZI SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 150MG/1ML	Skyrizi

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

6 more strength/form rows are recorded only in CA · SG and are not shown in this table. Hay 6 filas de concentración/forma registradas solo en CA · SG que no se muestran en esta tabla. 另有 6 个规格/剂型仅在 CA · SG 有记录（未在本表显示）。另有 6 個規格/劑型僅在 CA · SG 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.